Interestingly, among the known host factors involved in HCV entry, including those more recently described, such as EGFR, LDLR, TfR1, SRFBP1, and E-cadherin, none was significantly downregulated within the tumor with the exception of TACSTD2. The gene discussed is SRFBP1; the disease is neoplasm.